Obstacles to the Early Diagnosis and Management of Sarcopenia: Current Perspectives

References

• Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population‐based sample of community‐dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290–298. doi:10.1002/jcsm.12073
   PubMed Web of Science ®Google Scholar
• Zhang Y, Hao Q, Ge M, Dong B. Association of sarcopenia and fractures in community-dwelling older adults: a systematic review and meta-analysis of cohort studies. Osteoporos Int. 2018;29(6):1253–1262. doi:10.1007/s00198-018-4429-5
   PubMed Web of Science ®Google Scholar
• Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyère O, Wright JM. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169548. doi:10.1371/journal.pone.0169548
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis. Age Ageing. 2010;39(4):412–423. doi:10.1093/ageing/afq034
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy169
   PubMed Web of Science ®Google Scholar
• Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. doi:10.1016/j.jamda.2019.12.012
   PubMed Web of Science ®Google Scholar
• Rolland Y, Czerwinski S, van Kan GA, et al. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12(7):433–450. doi:10.1007/bf02982704
   PubMed Web of Science ®Google Scholar
• McLean RR, Shardell MD, Alley DE, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the national institutes of health (FNIH) sarcopenia project. J Gerontol a Biol Sci Med Sci. 2014;69(5):576–583. doi:10.1093/gerona/glu012
   PubMed Web of Science ®Google Scholar
• Petermann-Rocha F, Balntzi V, Gray SR, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta‐analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86–99. doi:10.1002/jcsm.12783
   PubMed Web of Science ®Google Scholar
• Schaap LA, van Schoor NM, Lips P, Visser M. Associations of sarcopenia definitions, and their components, with the incidence of recurrent falling and fractures: the longitudinal aging study Amsterdam. J Gerontol a Biol Sci Med Sci. 2018;73(9):1199–1204. doi:10.1093/gerona/glx245
   PubMed Web of Science ®Google Scholar
• Bao W, Sun Y, Zhang T, et al. Exercise programs for muscle mass, muscle strength and physical performance in older adults with sarcopenia: a systematic review and meta-analysis. Aging Dis. 2020;11(4):863. doi:10.14336/ad.2019.1012
   PubMed Web of Science ®Google Scholar
• Landi F, Cesari M, Calvani R, et al.; on behalf of the SPRINTT Consortium. The “Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies” (SPRINTT) randomized controlled trial: design and methods. Aging Clin Exp Res. 2017;29(1):89–100. doi:10.1007/s40520-016-0715-2
   PubMed Web of Science ®Google Scholar
• Talar K, Hernández-Belmonte A, Vetrovsky T, Steffl M, Kałamacka E, Courel-Ibáñez J. Benefits of resistance training in early and late stages of frailty and sarcopenia: a systematic review and meta-analysis of randomized controlled studies. J Clin Med. 2021;10(8):1630. doi:10.3390/jcm10081630
   PubMed Web of Science ®Google Scholar
• von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1(2):129–133. doi:10.1007/s13539-010-0014-2
   PubMed Web of Science ®Google Scholar
• Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; A quantitative review. Front Physiol. 2012;3. doi:10.3389/fphys.2012.00260
   PubMed Web of Science ®Google Scholar
• Welch C, Hassan-Smith ZK, Greig CA, Lord JM, Jackson TA. Acute sarcopenia secondary to hospitalisation - an emerging condition affecting older adults. Aging Dis. 2018;9(1):151. doi:10.14336/ad.2017.0315
   PubMed Web of Science ®Google Scholar
• Bauer J, Morley JE, Schols AMWJ, et al. Sarcopenia: a time for action. An SCWD position paper. J Cachexia Sarcopenia Muscle. 2019;10(5):956–961. doi:10.1002/jcsm.12483
   PubMed Web of Science ®Google Scholar
• Sayer AA, Cruz-Jentoft A. Sarcopenia definition, diagnosis and treatment: consensus is growing. Age Ageing. 2022;51(10). doi:10.1093/ageing/afac220
   Web of Science ®Google Scholar
• Welch C. Acute sarcopenia: definition and actual issues. In: Practical Issues in Geriatrics. Springer International Publishing; 2021:133–143.
   Google Scholar
• Ni Lochlainn M, Bowyer R, Steves C. Dietary protein and muscle in aging people: the potential role of the gut microbiome. Nutrients. 2018;10(7):929. doi:10.3390/nu10070929
   PubMed Web of Science ®Google Scholar
• Dodds RM, Syddall HE, Cooper R, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One. 2014;9(12):e113637. doi:10.1371/journal.pone.0113637
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Landi F, Topinková E, Michel JP. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care. 2010;13(1):1–7. doi:10.1097/mco.0b013e328333c1c1
   PubMed Web of Science ®Google Scholar
• Welch C, Greig C, Lewis D, et al. Trajectories of muscle quantity, quality and function measurements in hospitalized older adults. Geriatr Gerontol Int. 2022;22(4):311–318. doi:10.1111/ggi.14366
   PubMed Web of Science ®Google Scholar
• Welch C, Greig C, Majid Z, et al. Induced frailty and acute sarcopenia are overlapping consequences of hospitalisation in older adults. J Frailty Sarcopenia Falls. 2022;07(03):103–116. doi:10.22540/jfsf-07-103
   Google Scholar
• Bohannon RW. Minimal clinically important difference for grip strength: a systematic review. J Phys Ther Sci. 2019;31(1):75–78. doi:10.1589/jpts.31.75
   PubMedGoogle Scholar
• Rockwood K. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489–495. doi:10.1503/cmaj.050051
   PubMed Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol a Biol Sci Med Sci. 2001;56(3):M146–M157. doi:10.1093/gerona/56.3.m146
   PubMed Web of Science ®Google Scholar
• Evans WJ, Morley JE, Argilés J, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793–799. doi:10.1016/j.clnu.2008.06.013
   PubMed Web of Science ®Google Scholar
• Chen Y, Almirall-Sánchez A, Mockler D, Adrion E, Domínguez-Vivero C, Romero-Ortuño R. Hospital‐associated deconditioning: not only physical, but also cognitive. Int J Geriatr Psychiatry. 2022;37(3). doi:10.1002/gps.5687
   Web of Science ®Google Scholar
• Cesari M, Landi F, Vellas B, Bernabei R, Marzetti E. Sarcopenia and physical frailty: two sides of the same coin. Front Aging Neurosci. 2014;6. doi:10.3389/fnagi.2014.00192
   Web of Science ®Google Scholar
• Chong E, Bao M, Goh EF, Lim WS. SARC-F at the emergency department: diagnostic performance for frailty and predictive performance for reattendances and acute hospitalizations. J Nutr Health Aging. 2021;25(9):1084–1089. doi:10.1007/s12603-021-1676-5
   PubMed Web of Science ®Google Scholar
• Pachołek K, Sobieszczańska M. Sarcopenia identification during comprehensive geriatric assessment. Int J Environ Res Public Health. 2021;19(1):32. doi:10.3390/ijerph19010032
   PubMed Web of Science ®Google Scholar
• Lansbury LN, Roberts HC, Clift E, Herklots A, Robinson N, Sayer AA. Use of the electronic Frailty Index to identify vulnerable patients: a pilot study in primary care. Br J Gen Pract. 2017;67(664):e751–e756. doi:10.3399/bjgp17x693089
   PubMed Web of Science ®Google Scholar
• Reijnierse EM, de van der Schueren MAE, Trappenburg MC, Doves M, Meskers CGM, Maier AB. Lack of knowledge and availability of diagnostic equipment could hinder the diagnosis of sarcopenia and its management. PLoS One. 2017;12(10):e0185837. doi:10.1371/journal.pone.0185837
   PubMed Web of Science ®Google Scholar
• Sayer AA. Sarcopenia. BMJ. 2010;341(2):c4097. doi:10.1136/bmj.c4097
   PubMedGoogle Scholar
• Eckman M, Gigliotti C, Sutermaster S, Mehta K. Get a grip! Handgrip strength as a health screening tool. In: IEEE Global Humanitarian Technology Conference (GHTC 2014). IEEE; 2014.
   Google Scholar
• Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport. 1999;70(2):113–119. doi:10.1080/02701367.1999.10608028
   PubMed Web of Science ®Google Scholar
• Cawthon PM, Visser M, Arai H, et al. Defining terms commonly used in sarcopenia research: a glossary proposed by the Global Leadership in Sarcopenia (GLIS) Steering Committee. Eur Geriatr Med. 2022;13(6):1239–1244. doi:10.1007/s41999-022-00706-5
   PubMed Web of Science ®Google Scholar
• Welch C, Greig C, Masud T, Jackson TA. Muscle quantity and function measurements are acceptable to older adults during and post- hospitalisation: results of a questionnaire-based study. BMC Geriatr. 2021;21(1). doi:10.1186/s12877-021-02091-3
   PubMed Web of Science ®Google Scholar
• Perkisas S, Brockhattingen K, Welch C, Bahat G. Using ultrasound in the assessment of muscle. ejgg. 2021;3(1):1–3. doi:10.4274/ejgg.galenos.2021.2-1
   Google Scholar
• Welch C, Greig C, Majid Z, et al. The feasibility of conducting acute sarcopenia research in hospitalised older patients: a prospective cohort study. Eur Geriatr Med. 2022;13(2):463–473. doi:10.1007/s41999-021-00565-6
   PubMed Web of Science ®Google Scholar
• Akamatsu Y, Kusakabe T, Arai H, et al. Phase angle from bioelectrical impedance analysis is a useful indicator of muscle quality. J Cachexia Sarcopenia Muscle. 2022;13(1):180–189. doi:10.1002/jcsm.12860
   PubMed Web of Science ®Google Scholar
• Welch C, Majid Z, Andrews I, et al. Effect of position and exercise on measurement of muscle quantity and quality: towards a standardised pragmatic protocol for clinical practice. BMC Sports Sci Med Rehabil. 2021;13(1). doi:10.1186/s13102-020-00227-3
   PubMed Web of Science ®Google Scholar
• Stanley B, Greig C, Jackson T, et al. Investigating the impact of fluid status on the ultrasound assessment of muscle quantity and quality in the diagnosis of sarcopenia – a multidimensional cross-sectional study. BMC Geriatr. 2023;23(1). doi:10.1186/s12877-023-04177-6
   PubMed Web of Science ®Google Scholar
• Gomindes AR, Appleton JP, Chugh R, Welch C. Muscle quantity at C3 and/or L3 on routine trauma series computed tomography correlate with brain frailty and clinical frailty scale: a cross-sectional study. Cureus. 2021. doi:10.7759/cureus.15912
   PubMed Web of Science ®Google Scholar
• Beaudart C, McCloskey E, Bruyère O, et al. Sarcopenia in daily practice: assessment and management. BMC Geriatr. 2016;16(1). doi:10.1186/s12877-016-0349-4
   PubMedGoogle Scholar
• Cawthon PM. Assessment of lean mass and physical performance in sarcopenia. J Clin Densitom. 2015;18(4):467–471. doi:10.1016/j.jocd.2015.05.063
   PubMed Web of Science ®Google Scholar
• Bijlsma AY, Meskers CGM, van den Eshof N, et al. Diagnostic criteria for sarcopenia and physical performance. Age. 2014;36(1):275–285. doi:10.1007/s11357-013-9556-5
   PubMedGoogle Scholar
• Chen YM, Chuang YW, Liao SC, et al. Predictors of functional recovery (FR) for elderly hospitalized patients in a geriatric evaluation and management unit (GEMU) in Taiwan. Arch Gerontol Geriatr. 2010;50:S1–S5. doi:10.1016/s0167-4943(10)00041-5
   PubMed Web of Science ®Google Scholar
• Anita K, Biswas TK. A study of timed get up and go scores as falls risk assessment in elderly in a tertiary care centre. Int J Res Med Sci. 2020;8(3):841–846. doi:10.18203/2320-6012.ijrms20200519
   Google Scholar
• Freter SH, Fruchter N. Relationship between timed “up and go” and gait time in an elderly orthopaedic rehabilitation population. Clin Rehabil. 2000;14(1):96–101. doi:10.1191/026921500675545616
   PubMed Web of Science ®Google Scholar
• Riis J, Byrgesen SM, Kragholm KH, Mørch MM, Melgaard D. Validity of the GAITRite walkway compared to functional balance tests for fall risk assessment in geriatric outpatients. Geriatrics. 2020;5(4):77. doi:10.3390/geriatrics5040077
   PubMed Web of Science ®Google Scholar
• Geelen SJG, van Dijk - Huisman HC, de Bie RA, et al. Barriers and enablers to physical activity in patients during hospital stay: a scoping review. Syst Rev. 2021;10(1). doi:10.1186/s13643-021-01843-x
   PubMed Web of Science ®Google Scholar
• Offord NJ, Clegg A, Turner G, Dodds RM, Sayer AA, Witham MD. Current practice in the diagnosis and management of sarcopenia and frailty – results from a UK-wide survey. J Frailty Sarcopenia Falls. 2019;71–77. doi:10.22540/jfsf-04-071
   PubMedGoogle Scholar
• Dismore L, Hurst C, Sayer AA, Stevenson E, Aspray T, Granic A. Study of the older adults’ motivators and barriers engaging in a nutrition and resistance exercise intervention for sarcopenia: an embedded qualitative project in the MIlkMAN pilot study. Gerontol Geriatr Med. 2020;6:2333721420920398. doi:10.1177/2333721420920398
   Web of Science ®Google Scholar
• Nichikawa H, Asai A, Fukunishi S, Nishiguchi S, Higuchi K. Metabolic Syndrome and Sarcopenia. Nutrients. 2021;13(10):3519. doi:10.3390/nu13103519
   PubMed Web of Science ®Google Scholar
• Izzo A, Massimino E, Riccardi G, Della Pepa G. A narrative review on sarcopenia in type 2 diabetes mellitus: prevalence and associated factors. Nutrients. 2021;13(1):183. doi:10.3390/nu13010183
   PubMed Web of Science ®Google Scholar
• Couderc AL, Villani P, Berbis J, et al. HoSAGE: sarcopenia in older patient with intermediate / high-risk prostate cancer, prevalence and incidence after androgen deprivation therapy: study protocol for a cohort trial. BMC Cancer. 2022;22(1). doi:10.1186/s12885-021-09105-8
   PubMed Web of Science ®Google Scholar
• Witham MD, Achison M, Aspray TJ, et al. Recruitment strategies for sarcopenia trials: lessons from the LACE randomized controlled trial. JCSM Rapid Commun. 2021;4(2):93–102. doi:10.1002/rco2.38
   Google Scholar
• Reginster JY, Cooper C, Rizzoli R, et al. Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia. Aging Clin Exp Res. 2016;28(1):47–58. doi:10.1007/s40520-015-0517-y
   PubMed Web of Science ®Google Scholar
• Hurst C, Robinson SM, Witham MD, et al. Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age Ageing. 2022;51(2). doi:10.1093/ageing/afac003
   Web of Science ®Google Scholar
• O’Dowd A. NHS waiting list hits 14 year record high of 4.7 million people. BMJ. 2021;n995. doi:10.1136/bmj.n995
   PubMedGoogle Scholar
• Bury TJ, Stokes EK. A global view of direct access and patient self-referral to Physical Therapy: implications for the profession. Phys Ther. 2013;93(4):449–459. doi:10.2522/ptj.20120060
   PubMed Web of Science ®Google Scholar
• Haase CB, Brodersen JB, Bülow J. Sarcopenia: early prevention or overdiagnosis? BMJ. 2022;e052592. doi:10.1136/bmj-2019-052592
   PubMedGoogle Scholar
• Kwak JY, Kwon KS. Pharmacological interventions for treatment of sarcopenia: current status of drug development for sarcopenia. Ann Geriatr Med Res. 2019;23(3):98–104. doi:10.4235/agmr.19.0028
   PubMed Web of Science ®Google Scholar
• Yu X, Sun S, Zhang S, et al. A pooled analysis of the association between sarcopenia and osteoporosis. Medicine (Baltimore). 2022;101(46):e31692. doi:10.1097/md.0000000000031692
   PubMed Web of Science ®Google Scholar
• Vasudevan A, Ford E. Motivational factors and barriers towards initiating and maintaining strength training in women: a systematic review and meta-synthesis. Prev Sci. 2022;23(4):674–695. doi:10.1007/s11121-021-01328-2
   PubMed Web of Science ®Google Scholar
• Gielen E, Beckwée D, Delaere A, et al. Nutritional interventions to improve muscle mass, muscle strength, and physical performance in older people: an umbrella review of systematic reviews and meta-analyses. Nutr Rev. 2021;79(2):121–147. doi:10.1093/nutrit/nuaa011
   PubMed Web of Science ®Google Scholar
• Chang MC, Choo YJ. Effects of whey protein, leucine, and vitamin D supplementation in patients with sarcopenia: a systematic review and meta-analysis. Nutrients. 2023;15(3):521. doi:10.3390/nu15030521
   PubMed Web of Science ®Google Scholar
• Prokopidis K, Giannos P, Katsikas Triantafyllidis K, et al. Effect of vitamin D monotherapy on indices of sarcopenia in community‐dwelling older adults: a systematic review and meta‐analysis. J Cachexia Sarcopenia Muscle. 2022;13(3):1642–1652. doi:10.1002/jcsm.12976
   PubMed Web of Science ®Google Scholar
• Ikeda T, Katayama S, Kitagawa T. The combined intervention of neuromuscular electrical stimulation and nutrition therapy: a scoping review. Clin Nutr ESPEN. 2023;54:239–250. doi:10.1016/j.clnesp.2023.01.027
   PubMed Web of Science ®Google Scholar
• Mellen RH, Girotto OS, Marques EB, et al. Insights into pathogenesis, nutritional and drug approach in sarcopenia: a systematic review. Biomedicines. 2023;11(1):136. doi:10.3390/biomedicines11010136
   PubMed Web of Science ®Google Scholar
• Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510–520. doi:10.1258/jrsm.2011.110180
   PubMed Web of Science ®Google Scholar